Antidepressants ineffective for under 18s

A clear winner emerges from among 14 drug treatments, but more quality data is needed Fluoxetine is probably the best option to consider when a pharmacological treatment is indicated for children and adolescents with major depressive disorder, according to a meta-analysis published in The Lancet. A review of 34 trials comprising 5260 participants with an

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Cardiovascular health linked to diabetes risk
Next New oral antineoplastic drugs resource